1. |
Drummond GS, Kappas A. Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model. Science, 1982, 217(4566): 1250-1252.
|
2. |
Rodgers PA, Stevenson DK. Developmental biology of heme oxygenase. Clin Perinatol, 1990, 17(2): 275-291.
|
3. |
Cisowski J, Loboda A, Jozkowicz A, et al. Role of hemeoxygenase-1 in hydrogen peroxide-induced VEGF synthesis: effect of HO-1 knockout. Biochem Biophys Res Commun, 2005, 326(3): 670-676.
|
4. |
Ferrando M, Gueron G, Elguero B, Giudice J, et al. Hemeoxygenase-1(HO-1) challenges the angiogenic switch in prostate cancer. Angiogenesis, 2011, 14(4): 467-479.
|
5. |
Wu M, Huang J, Xu S, et al. Hemeoxygenase-1 delays programmed cell death in wheat aleurone layers by modulation of hydrogen peroxide metabolism. J Exp Bot, 2011, 62(1): 235-248.
|
6. |
Bao W, Song F, Li X, et al. Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus. PLoS One, 2010, 5(8): e12371.
|
7. |
Miyake M, Fujimoto K, Anai S, et al. Heme oxygenase-1promotes angiogenesis in urothelial carcinoma of the urinary bladder. Oncol Rep, 2011, 25(3): 653-660.
|
8. |
Jee SH, AOhrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in Korean men and women. JAMA, 2005, 293(2): 194-202.
|
9. |
Sato T, Takeno M, Honma K, et al. Heme oxygenase-1, a potential biomarker of chronic silicosis, attenuates silica-induced lung injury. Am J Respir Crit Care Med, 2006, 174(8): 906-914.
|
10. |
Mateo I, Infante J, Sanchez-Juan P, et al. Serum heme oxygenase-1 levels are increased in Parkinson’s disease but not in Alzheimer’s disease. Acta Neurol Scand, 2010, 121(2): 136-138.
|
11. |
Miyazaki T, Kirino Y, Takeno M, et al. Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions. Int J Hematol, 2010, 91(2): 229-237.
|
12. |
Susztak K, Raff AC, Schiffer M, et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes, 2006, 55(1): 225-233.
|
13. |
Wu WS. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev, 2006, 25(4): 695-705.
|
14. |
Li H, van Berlo D, Shi T, et al. Curcumin protects against cytotoxic and inflammatory effects of quartz particles but causes oxidative DNA damage in a rat lung epithelial cell line. Toxicol Appl Pharmacol, 2008, 227(1): 115-124.
|
15. |
Zuo L, Youtz DJ, Wold LE. Particulate matter exposure exacerbates high glucose-induced cardiomyocyte dysfunction through ROS generation. PLoS One, 2011, 6(8): e23116.
|
16. |
Toyonaga J, Tsuruya K, Ikeda H, et al. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. Nephrol Dial Transplant, 2011, 26(8): 2475-2484.
|
17. |
Bonnefont-Rousselot D, Bastard JP, Jaudon MC, et al. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab, 2000, 26(3): 163-176.
|
18. |
Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species production throughprotein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes, 2000, 49(11): 1939-1945.
|
19. |
Singh R, Barden A, Mori T, et al. Advanced glycation endproducts: a review. Diabetologia, 2001, 44(2): 129-146.
|
20. |
Alisson-Silva F, Freire-de-Lima L, Donadio JL, et al. Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells. PLoS One, 2013, 8(4): e60471.
|
21. |
李军涛, 张恒伟, 郭旭辉, 等. 高糖对人乳腺癌细胞体外侵袭能力的影响. 中华医学杂志, 2013, 93(2): 89-92.
|
22. |
Li W, Ma Q, Li J, et al. Hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide. Oncol Rep, 2011, 25(5): 1279-1287.
|